Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.

Di Tanna GL, Khaki AR, Theron G, McCarthy K, Cox H, Mupfumi L, Trajman A, Zijenah LS, Mason P, Bandason T, Durovni B, Bara W, Hoelscher M, Clowes P, Mangu C, Chanda D, Pym A, Mwaba P, Cobelens F, Nicol MP, Dheda K, Churchyard G, Fielding K, Metcalfe JZ.

Lancet Glob Health. 2019 Feb;7(2):e191-e199. doi: 10.1016/S2214-109X(18)30458-3. Erratum in: Lancet Glob Health. 2019 Apr;7(4):e419.

2.

KIR and HLA-C Genetic Polymorphisms Influence Plasma IP-10 Concentration in Antiretroviral Therapy-Naive HIV-Infected Adult Zimbabweans.

Mhandire K, Zijenah LS, Tshabalala M, Yindom LM, Mlambo T, Mhandire DZ, Musarurwa C, Duri K, Rowland-Jones S, Dandara C, Stray-Pedersen B.

OMICS. 2019 Feb;23(2):111-118. doi: 10.1089/omi.2018.0147. Epub 2019 Jan 7.

PMID:
30614763
3.

Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: a cross sectional study.

Musarurwa C, Zijenah LS, Mhandire DZ, Bandason T, Mhandire K, Chipiti MM, Munjoma MW, Mujaji WB.

BMC Pulm Med. 2018 May 8;18(1):67. doi: 10.1186/s12890-018-0640-6.

4.

Plasma IP-10 Concentrations Correlate Positively with Viraemia and Inversely with CD4 Counts in Untreated HIV Infection.

Mhandire K, Mlambo T, Zijenah LS, Duri K, Mateveke K, Tshabalala M, Mhandire DZ, Musarurwa C, Wekare PT, Mazengera LR, Matarira HT, Stray-Pedersen B.

Open AIDS J. 2017 Apr 26;11:24-31. doi: 10.2174/1874613601711010024. eCollection 2017.

5.

Association of high serum vitamin D concentrations with active pulmonary TB in an HIV co-endemic setting, Harare, Zimbabwe.

Musarurwa C, Zijenah LS, Duri DZ, Mateveke-Dangaiso K, Mhandire K, Chipiti MM, Munjoma MW, Mujaji WB.

BMC Infect Dis. 2017 Feb 13;17(1):142. doi: 10.1186/s12879-017-2243-x.

6.

Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial.

Calligaro GL, Zijenah LS, Peter JG, Theron G, Buser V, McNerney R, Bara W, Bandason T, Govender U, Tomasicchio M, Smith L, Mayosi BM, Dheda K.

Lancet Infect Dis. 2017 Apr;17(4):441-450. doi: 10.1016/S1473-3099(16)30384-X. Epub 2017 Jan 5.

PMID:
28063795
7.

KIR Gene Content Diversity in a Zimbabwean Population: Does KIR2DL2 Have a Role in Protection Against Human Immunodeficiency Virus Infection?

Mhandire K, Zijenah LS, Yindom LM, Duri K, Mlambo T, Tshabalala M, Mazengera LR, Mhandire DZ, Musarurwa C, Dandara C, Rowland-Jones S, Matarira HT, Stray-Pedersen B.

OMICS. 2016 Dec;20(12):727-735.

PMID:
27930093
8.

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.

Peter JG, Zijenah LS, Chanda D, Clowes P, Lesosky M, Gina P, Mehta N, Calligaro G, Lombard CJ, Kadzirange G, Bandason T, Chansa A, Liusha N, Mangu C, Mtafya B, Msila H, Rachow A, Hoelscher M, Mwaba P, Theron G, Dheda K.

Lancet. 2016 Mar 19;387(10024):1187-97. doi: 10.1016/S0140-6736(15)01092-2. Epub 2016 Mar 10.

PMID:
26970721
9.

Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe.

Zijenah LS, Kadzirange G, Bandason T, Chipiti MM, Gwambiwa B, Makoga F, Chungu P, Kaguru P, Dheda K.

BMC Infect Dis. 2016 Jan 22;16:20. doi: 10.1186/s12879-016-1339-z.

10.

Naturally-occurring genetic variants in human DC-SIGN increase HIV-1 capture, cell-transfer and risk of mother-to-child transmission.

Boily-Larouche G, Milev MP, Zijenah LS, Labbé AC, Zannou DM, Humphrey JH, Ward BJ, Poudrier J, Mouland AJ, Cohen EA, Roger M.

PLoS One. 2012;7(7):e40706. doi: 10.1371/journal.pone.0040706. Epub 2012 Jul 10.

11.

Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe.

Tshabalala M, Manasa J, Zijenah LS, Rusakaniko S, Kadzirange G, Mucheche M, Kassaye S, Johnston E, Katzenstein D.

PLoS One. 2011;6(6):e21241. doi: 10.1371/journal.pone.0021241. Epub 2011 Jun 16.

12.

Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis.

Gantt S, Carlsson J, Heath L, Bull ME, Shetty AK, Mutsvangwa J, Musingwini G, Woelk G, Zijenah LS, Katzenstein DA, Mullins JI, Frenkel LM.

J Virol. 2010 Oct;84(20):10812-9. doi: 10.1128/JVI.00543-10. Epub 2010 Jul 21.

13.

Functional genetic variants in DC-SIGNR are associated with mother-to-child transmission of HIV-1.

Boily-Larouche G, Iscache AL, Zijenah LS, Humphrey JH, Mouland AJ, Ward BJ, Roger M.

PLoS One. 2009 Oct 7;4(10):e7211. doi: 10.1371/journal.pone.0007211.

14.

Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis.

Gantt S, Carlsson J, Shetty AK, Seidel KD, Qin X, Mutsvangwa J, Musingwini G, Woelk G, Zijenah LS, Katzenstein DA, Frenkel LM.

AIDS. 2008 Jul 31;22(12):1453-60. doi: 10.1097/QAD.0b013e32830184f2.

15.

CD4 T cell measurements in the management of antiretroviral therapy--A review with an emphasis on pediatric HIV-infected patients.

O'Gorman MR, Zijenah LS.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S19-26. doi: 10.1002/cyto.b.20398. Review.

17.

Laboratory indicators of mastitis are not associated with elevated HIV-1 DNA loads or predictive of HIV-1 RNA loads in breast milk.

Gantt S, Shetty AK, Seidel KD, Matasa K, Musingwini G, Woelk G, Zijenah LS, Katzenstein DA, Frenkel LM.

J Infect Dis. 2007 Aug 15;196(4):570-6. Epub 2007 Jun 29.

PMID:
17624843
18.

DC-SIGN and DC-SIGNR genetic diversity among different ethnic populations: potential implications for pathogen recognition and disease susceptibility.

Boily-Larouche G, Zijenah LS, Mbizvo M, Ward BJ, Roger M.

Hum Immunol. 2007 Jun;68(6):523-30. Epub 2007 Mar 12.

PMID:
17509452
19.

HIV-1 and HIV-2 prevalence and associated risk factors among postnatal women in Harare, Zimbabwe.

Humphrey JH, Nathoo KJ, Hargrove JW, Iliff PJ, Mutasa KE, Moulton LH, Chidawanyika H, Malaba LC, Zijenah LS, Zvandasara P, Ntozini R, Zunguza CD, Ward BJ; ZVITAMBO Study Group.

Epidemiol Infect. 2007 Aug;135(6):933-42. Epub 2007 Jan 12.

20.
21.

Mortality and morbidity among postpartum HIV-positive and HIV-negative women in Zimbabwe: risk factors, causes, and impact of single-dose postpartum vitamin A supplementation.

Zvandasara P, Hargrove JW, Ntozini R, Chidawanyika H, Mutasa K, Iliff PJ, Moulton LH, Mzengeza F, Malaba LC, Ward BJ, Nathoo KJ, Zijenah LS, Mbizvo M, Zunguza C, Humphrey JH; ZVITAMBO Study Group.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):107-16.

PMID:
16885772
22.

HIV incidence among post-partum women in Zimbabwe: risk factors and the effect of vitamin A supplementation.

Humphrey JH, Hargrove JW, Malaba LC, Iliff PJ, Moulton LH, Mutasa K, Zvandasara P, Nathoo KJ, Mzengeza F, Chidawanyika H, Zijenah LS, Ward BJ; ZVITAMBO Study Group.

AIDS. 2006 Jun 26;20(10):1437-46.

PMID:
16791019
23.

Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality.

Humphrey JH, Iliff PJ, Marinda ET, Mutasa K, Moulton LH, Chidawanyika H, Ward BJ, Nathoo KJ, Malaba LC, Zijenah LS, Zvandasara P, Ntozini R, Mzengeza F, Mahomva AI, Ruff AJ, Mbizvo MT, Zunguza CD; ZVITAMBO Study Group.

J Infect Dis. 2006 Mar 15;193(6):860-71. Epub 2006 Feb 8. Erratum in: J Infect Dis. 2008 May 15;197(10):1485.

PMID:
16479521
24.
25.

Signal-boosted qualitative ultrasensitive p24 antigen assay for diagnosis of subtype C HIV-1 infection in infants under the age of 2 years.

Zijenah LS, Tobaiwa O, Rusakaniko S, Nathoo KJ, Nhembe M, Matibe P, Katzenstein DA.

J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):391-4.

PMID:
16010158
26.

CYP3A5 genetic polymorphisms in different ethnic populations.

Roy JN, Lajoie J, Zijenah LS, Barama A, Poirier C, Ward BJ, Roger M.

Drug Metab Dispos. 2005 Jul;33(7):884-7. Epub 2005 Apr 15.

PMID:
15833928
27.

Effect of postpartum maternal or neonatal vitamin A supplementation on infant mortality among infants born to HIV-negative mothers in Zimbabwe.

Malaba LC, Iliff PJ, Nathoo KJ, Marinda E, Moulton LH, Zijenah LS, Zvandasara P, Ward BJ, Humphrey JH; ZVITAMBO Study Group.

Am J Clin Nutr. 2005 Feb;81(2):454-60.

PMID:
15699235
28.

T lymphocytes among HIV-infected and -uninfected infants: CD4/CD8 ratio as a potential tool in diagnosis of infection in infants under the age of 2 years.

Zijenah LS, Katzenstein DA, Nathoo KJ, Rusakaniko S, Tobaiwa O, Gwanzura C, Bikoue A, Nhembe M, Matibe P, Janossy G.

J Transl Med. 2005 Feb 1;3(1):6.

29.

Survival pattern among infants born to human immunodeficiency virus type-1 infected mothers and uninfected mothers in Harare, Zimbabwe.

Nathoo K, Rusakaniko S, Zijenah LS, Kasule J, Mahomed K, Mashu A, Choto R, Mbizvo M.

Cent Afr J Med. 2004 Jan-Feb;50(1-2):1-6. Erratum in: Cent Afr J Med. 2004 May-Jun;50(5-6):57.

PMID:
15490717
30.

Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women.

Matte C, Lajoie J, Lacaille J, Zijenah LS, Ward BJ, Roger M.

AIDS. 2004 Feb 20;18(3):427-31.

PMID:
15090794
31.

Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe.

Zijenah LS, Moulton LH, Iliff P, Nathoo K, Munjoma MW, Mutasa K, Malaba L, Zvandasara P, Ward BJ, Humphrey J; ZVITAMBO Study Group.

AIDS. 2004 Jan 23;18(2):273-80.

PMID:
15075545
32.

Mycobacterium tuberculosis/HIV-1 coinfection and disease: role of human leukocyte antigen variation.

Louie LG, Hartogensis WE, Jackman RP, Schultz KA, Zijenah LS, Yiu CH, Nguyen VD, Sohsman MY, Katzenstein DK, Mason PR.

J Infect Dis. 2004 Mar 15;189(6):1084-90. Epub 2004 Feb 27.

PMID:
14999612
33.

Novel TAP1 polymorphisms in indigenous Zimbabweans: their potential implications on TAP function and in human diseases.

Lajoie J, Zijenah LS, Faucher MC, Ward BJ, Roger M; ZVITAMBO Study Group.

Hum Immunol. 2003 Aug;64(8):823-9.

PMID:
12878362
34.

New transporter associated with antigen processing (TAP-2) polymorphisms in the Shona people of Zimbabwe.

Lajoie J, Zijenah LS, Faucher MC, Ward BJ, Roger M; ZVITAMBO Study Group.

Hum Immunol. 2003 Jul;64(7):733-40.

PMID:
12826376
35.
36.

HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.

Kantor R, Zijenah LS, Shafer RW, Mutetwa S, Johnston E, Lloyd R, von Lieven A, Israelski D, Katzenstein DA.

AIDS Res Hum Retroviruses. 2002 Dec 10;18(18):1407-13.

37.

Mother-to-child human leukocyte antigen G concordance: no impact on the risk of vertical transmission of HIV-1.

Matte C, Zijenah LS, Lacaille J, Ward B, Roger M.

AIDS. 2002 Dec 6;16(18):2491-4. No abstract available.

PMID:
12461430
38.

Association of high HIV-1 RNA levels and homozygosity at HLA class II DRB1 in adults coinfected with Mycobacterium tuberculosis in Harare, Zimbabwe.

Zijenah LS, Hartogensis WE, Katzenstein DA, Tobaiwa O, Mutswangwa J, Mason PR, Louie LG.

Hum Immunol. 2002 Nov;63(11):1026-32.

PMID:
12392855
39.

Maternal HIV-1 antibody and vertical transmission in subtype C virus infection.

Guevara H, Casseb J, Zijenah LS, Mbizvo M, Oceguera LF 3rd, Hanson CV, Katzenstein DA, Hendry RM.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):435-40.

PMID:
11981358
41.

Evaluation of the prototype Roche DNA amplification kit incorporating the new SSK145 and SKCC1B primers in detection of human immunodeficiency virus type 1 DNA in Zimbabwe.

Zijenah LS, Humphrey J, Nathoo K, Malaba L, Zvandasara P, Mahomva A, Iliff P, Mbizvo MT.

J Clin Microbiol. 1999 Nov;37(11):3569-71.

42.
44.

Integrin-dependent platelet recognition sites in collagen: identification of a short platelet-reactive sequence in the type III-derived fragment alpha 1(III) CB3.

Morton LF, Zijenah LS, McCulloch IY, Knight CG, Humphries MJ, Barnes MJ.

Biochem Soc Trans. 1991 Nov;19(4):439S. No abstract available.

PMID:
1794556
46.

Supplemental Content

Loading ...
Support Center